Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04973696 · ClinicalTrials.gov registry record · NA

Toolkit for Optimal Recovery After Orthopedic Injury

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
195
Enrollment target

NCT04973696: Completed NA study, sponsored by Massachusetts General Hospital.

NCT04973696 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 195 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04973696, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
195 participants
Enrollment target

Study Summary

This is a multi-site randomized feasibility trial of the Toolkit for Optimal Recovery after Orthopedic Injury (TOR), a mind-body program to prevent persistent pain and disability in at-risk patients with acute orthopedic injury, versus a minimally-enhanced usual care (MEUC) control. TOR is a 4-session program delivered via secure live video to patients at risk for chronic pain, 1-2 months after an orthopedic traumatic injury. The primary aim of this study is to determine whether the study methodology (i.e., implementation, randomization, procedures and assessment of outcome measures) and delivery of TOR meet a priori set benchmarks for feasibility, acceptability, and appropriateness, necessary for the success of the subsequent efficacy trial.

Interventions

  • BEHAVIORAL Toolkit for Optimal Recovery after Orthopedic Injury
  • OTHER Minimally Enhanced Usual Care (MEUC)

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2021-09-21
Est. Completion 2023-08-15
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04973696

The ClinicalTrials.gov registry entry for NCT04973696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Toolkit for Optimal Recovery after Orthopedic Injury is the first listed.

NCT04973696 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04973696 about?

NCT04973696 is a clinical study titled "Toolkit for Optimal Recovery After Orthopedic Injury". This is a multi-site randomized feasibility trial of the Toolkit for Optimal Recovery after Orthopedic Injury (TOR), a mind-body program to prevent persistent pain and disability in at-risk patients with acute orthopedic injury, versus a minimally-enhanced usual care (MEUC) control. TOR is a 4-sessi...

What is the current status of trial NCT04973696?

This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2021-09-21. Estimated completion is 2023-08-15.

What interventions are being tested in trial NCT04973696?

The interventions under investigation include: Toolkit for Optimal Recovery after Orthopedic Injury (BEHAVIORAL), Minimally Enhanced Usual Care (MEUC) (OTHER).

Who is sponsoring clinical trial NCT04973696?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.